NasdaqGS - Delayed Quote • USD
Inogen, Inc. (INGN)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:02 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.76 | -0.6 | -2.5 | -1.96 |
| Low Estimate | -0.85 | -0.7 | -2.63 | -2.3 |
| High Estimate | -0.65 | -0.5 | -2.31 | -1.35 |
| Year Ago EPS | -0.88 | -0.42 | -4.42 | -2.5 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 73.66M | 84.17M | 323.45M | 338.42M |
| Low Estimate | 73M | 79M | 316M | 332M |
| High Estimate | 74.5M | 88.1M | 330.4M | 345.3M |
| Year Ago Sales | 72.16M | 83.64M | 315.66M | 323.45M |
| Sales Growth (year/est) | 2.10% | 0.60% | 2.50% | 4.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.78 | -0.59 | -0.49 | -0.62 |
| EPS Actual | -0.88 | -0.42 | -1.97 | -1.14 |
| Difference | -0.1 | 0.17 | -1.48 | -0.52 |
| Surprise % | -12.80% | 28.80% | -302.00% | -83.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.76 | -0.6 | -2.5 | -1.96 |
| 7 Days Ago | -0.76 | -0.6 | -2.5 | -1.96 |
| 30 Days Ago | -0.76 | -0.6 | -2.5 | -1.96 |
| 60 Days Ago | -0.62 | -0.59 | -2.27 | -2.13 |
| 90 Days Ago | -0.62 | -0.59 | -2.27 | -2.13 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | INGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 13.60% | -- | -- | 1.50% |
| Next Qtr. | -42.90% | -- | -- | 11.40% |
| Current Year | 43.40% | -- | -- | 5.20% |
| Next Year | 21.60% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -207.80% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -14.67% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Needham: Hold | 4/9/2024 |
| Upgrade | William Blair: Market Perform to Outperform | 2/15/2024 |
| Maintains | JP Morgan: Underweight to Underweight | 11/8/2023 |
| Maintains | Stifel: Hold to Hold | 8/8/2023 |
| Downgrade | JP Morgan: Neutral to Underweight | 8/8/2023 |
| Downgrade | Needham: Buy to Hold | 7/14/2023 |
Related Tickers
SGHT Sight Sciences, Inc.
5.62
-0.35%
LUNG Pulmonx Corporation
7.52
+0.27%
MODD Modular Medical, Inc.
1.5800
+0.64%
OFIX Orthofix Medical Inc.
13.56
+2.57%
CVRX CVRx, Inc.
14.40
+0.77%
MXCT MaxCyte, Inc.
3.7400
-1.58%
FNA Paragon 28, Inc.
9.64
-4.08%
LIVN LivaNova PLC
55.94
+1.67%
AXGN AxoGen, Inc.
6.87
-1.43%
SILK Silk Road Medical, Inc
17.57
-0.57%